New combo attack on spine cancer
NCT ID NCT05204290
Summary
This early-stage study tested whether combining a precise form of radiation (radiosurgery) with an immunotherapy drug (pembrolizumab) is safe and feasible for people with aggressive spinal tumors. The main goal was to see if patients could complete both treatments. Researchers also wanted to measure if the treatment reduced pain, improved quality of life, and shrank the tumors to relieve pressure on the spinal cord.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.